Reference 2017-513

REF:            2017-513

Subject:        Intra-vitreal injections/implants

    

 

Request:

Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between May and August 2017?

If your trust is able to identify injections/implants by eye conditions please split by the drug used [ranibizumab, bevacizumab, aflibercept, Fluocinolone and Dexamethasone].

  Lucentis (ranibizumab) Injections Avastin (bevacizumab) Injections Eylea (aflibercept) Injections Illuvien (Fluocinolone) Impants Ozudex (Dexamethasone) Implants
Total          
Wet Age Related Macular Degeneration (wAMD)          
Diabetic Macular Oedema (DMO)          
Retinal Vein Occlusion – Central or Branch (CRVO or BRVO)          
Other eg mCNV          

 

Response:

Please find information attached.

2017-513 FOI Request intra-vitreal injections implants [13 kb] Ms Excel